Australia could become an Asia-Pacific hub for the manufacture of cell and gene therapy products due to the country’s research, clinical trial, and advanced hospital system strengths, according to a new industry-led report. The National Cell and Gene Manufacturing Blueprint aims to provide a unified and collaborative approach to boosting Australia’s sovereign cell and gene (C&G)…

The post Australia could be cell and gene therapy powerhouse: AusBiotech appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.